Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma

NCT01884688 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT01884688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01884688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma
Lead sponsor
University of Arkansas
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2013
Completion date
October 31, 2016
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asymptomatic multiple myeloma